Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI)

Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI)

US Patent 12098428 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prodigiosin analogs and methods of use2025
miR-3132 upregulation of the trail pathway and apoptotic activity in cancer cell2024
Small molecule trail gene induction by normal and tumor cells as an anticancer t2024
Prodigiosin analogs and methods of use2024
Treatment of tumors with miRNA targeting CDK4/CDK62024
miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cell2023
Prodigiosin analogs and methods of use2022
Compounds for repressing cancer cell growth2021
Treatment of tumors with miRNA targeting CDK4/CDK62021
Dual inhibition of CDK and HSP90 destabilize H1F1 α and synergistically induces 2021
Prodigiosin analogs and methods of use2020
Compound for anti-cancer therapy that acts by targeting GOF mutant p53 and stimu2020